Clinical Trial Update: Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on repeated DermaVir immunizations in treatment-naïve HIV-1 infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DermaVir

Snippet

Sponsor: Genetic Immunity | Conditions: HIV Infection | Phase 2 | Status: COMPLETED